These trials completed more than 12 months ago and should have reported results.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Trial is outside EEC 2026-000102-34 A phase III single-center, randomized, double-blinded, parallel-group, active-controlled study to evaluate the efficacy and safety of a single dose of emodepside compared to multiple doses of mebendaz... bad-data